Collaborative Pre-competitive Preclinical Drug Discovery with Academics and Pharma/Biotech Partners at Sanford|Burnham: Infrastructure, Capabilities & Operational models

Publisher： Bentham Science Publishers

E-ISSN： 1875-5402|17|3|272-289

ISSN： 1386-2073

Source： Combinatorial Chemistry & High Throughput Screening, Vol.17, Iss.3, 2014-03, pp. : 272-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Operational Models of Infrastructure Resilience

By  

RISK ANALYSIS, Vol. 35, Iss. 4, 2015-04 ,pp. : 562-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Content Analysis in Preclinical Drug Discovery

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 11, Iss. 3, 2008-03 ,pp. : 216-230

Bentham Science Publishers

Access to resources Recommend Favorite

Bridging the Strategic Gap Between Biotech and Pharma Companies

By Tiedemann Gudrun  

CHIMIA International Journal for Chemistry, Vol. 58, Iss. 11, 2004-11 ,pp. : 805-807

Swiss Chemical Society

Access to resources Recommend Favorite

Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

By Dyson Paul J.  

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 11, 2007-11 ,pp. : 698-703

Swiss Chemical Society

Access to resources Recommend Favorite

Polymer Membrane and Cell Models for Drug Discovery

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 15, Iss. 1, 2012-01 ,pp. : 3-14

Bentham Science Publishers

Access to resources Recommend Favorite